|
Gene name | Aliases | GO annotations | Previous associated diseases | Novel biological significance in IBD | References |
|
PTGS2 | Prostaglandin-endoperoxide synthase 2 | Protein homodimerization activity and lipid binding | Colorectal adenoma and peptic ulcer disease | Inhibiting T cell activation and promoting regulatory T cell development | [38–40] |
|
LY75 | Lymphocyte antigen 75 | Receptor activity and carbohydrate binding | Hodgkin lymphoma and lipid pneumonia | Participating in T cell function and homeostasis | [41, 42] |
|
CD28 | CD28 molecule | Identical protein binding and SH3/SH2 adaptor activity | Sezary’s disease and mycosis fungoides | A key costimulatory molecule in T cell activation and preventing aberrant immunological responses to intestinal antigens | [43, 44] |
|
CCL20 | C-C motif chemokine ligand 20 | Cytokine activity and chemokine activity | Rheumatoid arthritis and bejel | Regulating the migration of T cells (especially regulatory T cells) and dendritic cells to the gut | [45–47] |
|
NFKBIZ | NFKB inhibitor zeta | Transcription cofactor activity | Myxoid liposarcoma and brain glioblastoma multiforme | Activate natural killer cell, recruiting monocyte, and regulating Th17 development with ROR nuclear receptors | [48, 49] |
|
OSMR | Oncostatin M receptor | Growth factor binding and oncostatin M receptor activity | Amyloidosis, primary localized cutaneous, 1 and amyloidosis | Promoting intestinal epithelial cell proliferation and wound healing | [50] |
|
AHR | Aryl hydrocarbon receptor | Transcription factor activity, sequence-specific DNA binding and protein heterodimerization activity | Eosinophilic fasciitis and seborrheic dermatitis | Maintaining intraepithelial lymphocyte homeostasis and controlling intestinal microbial load and composition | [51, 52] |
|
PTK2B | Protein tyrosine kinase 2 beta | Transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity | Transient cerebral ischemia and osteoporosis | Monocyte migration and neutrophil degranulation | [53] |
|
NFATC1 | Nuclear factor of activated T cells 1 | Transcription factor activity, sequence-specific DNA binding, and transcription regulatory region DNA binding | Bone epithelioid hemangioma and ventricular septal defect | Supporting lymphocyte proliferation and inhibiting activation-induced cell death | [54, 55] |
|